Wilmington, DE, United States of America

Laurine G Galya

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Incyte Corporation, Incyte Holdings Corporation. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurine G Galya. Retrieved from https://idiyas.com/inventor/laurine-g-galya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 198(Granted Patents)

Company Filing History:

Incyte Holdings Corporation

patents

where one patent can have more than one assignee

Years Active: 2013-2016

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9512161 - Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile (2016-12-06),

2. 8748401 - Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile (2014-06-10),

3. 8486902 - Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile (2013-07-16),

Title: Laurine G Galya: Innovator in Pharmaceutical Chemistry

Introduction

Laurine G Galya is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on various chemical derivatives. With a total of 3 patents, her research has the potential to impact drug development and therapeutic applications.

Latest Patents

Laurine's latest patents focus on hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile. These inventions provide valuable insights into the chemical modifications that can enhance the efficacy and safety of pharmaceutical compounds. The detailed descriptions of her patents highlight the innovative approaches she has taken in her research.

Career Highlights

Throughout her career, Laurine has worked with notable companies such as Incyte Corporation and Incyte Holdings Corporation. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research initiatives.

Collaborations

Laurine has collaborated with talented individuals, including James David Rodgers and Adam Shilling. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions in pharmaceutical chemistry.

Conclusion

Laurine G Galya is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for advancements in drug development. Her contributions through her patents and collaborations reflect her commitment to innovation and excellence in her field.

Profile summary based on public USPTO records.